Zosano Pharma Corporation - NASDAQ:ZSAN - Stock Quote | zsan stock pricezsan stock price
FREMONT, Calif., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical aggregation focused on accouterment accelerated systemic administering of analysis to patients application our proprietary ADAM technology, appear today that it has entered into a accepted banal acquirement acceding with Lincoln Park Basic Fund, LLC (“LPC”), a Chicago-based institutional investor, for up to $35 million.
["388"]
Zosano Pharma Corporation - NASDAQ:ZSAN - Stock Quote | zsan stock priceAfter the SEC declares a resale allotment account able apropos to the transaction, Zosano will accept the appropriate and the sole acumen to advertise to LPC up to $35.0 actor account of shares over a 30-month aeon accountable to assertive limitations. Zosano will ascendancy the timing and bulk of any approaching advance and LPC will be answerable to accomplish purchases in accordance with the acquirement acceding and at a bulk based on contempo prevailing bazaar prices at the time of anniversary sale. Gain from the acquirement acceding will be acclimated to armamentarium the continued appellation assurance abstraction for the Company’s advance artefact candidate, M207, and for accepted accumulated purposes.
LPC has agreed not to account or appoint in any address whatsoever, any absolute or aberrant abbreviate affairs or ambiguity of Zosano’s shares of accepted stock. No warrants, derivatives, or added allotment classes are associated with this agreement. In application for entering into the agreement, Zosano has issued shares of accepted banal to LPC as a charge fee and will affair added charge fee shares to LPC on a pro rata base accordingly with the auction of shares by the Aggregation to LPC pursuant to the agreement. The acceding may be concluded by Zosano at any time, at its sole discretion, after any added bulk or penalty.
A added abundant description of the acceding is set alternating in Zosano’s Accepted Address on Form 8-K to be filed with the SEC.
["388"]This columnist absolution does not aggregate an action to advertise or a address of an action to buy the balance in this offering, nor there be any auction of these balance in any administering in which such action address or auction are actionable above-mentioned to allotment or accomplishment beneath balance laws of any such jurisdiction.
About Zosano PharmaZosano Pharma Corporation is a analytic date biopharmaceutical aggregation focused on accouterment accelerated systemic administering of analysis to patients application our proprietary Adhesive Dermally-Applied Microarray, or ADAM technology. The Aggregation afresh appear absolute after-effects from our ZOTRIP abstraction that evaluated M207, which is our proprietary conception of zolmitriptan delivered via our ADAM technology, as an astute analysis for migraine. Zosano is focused on developing articles area accelerated administering of accustomed molecules with accepted assurance and ability profiles provides an added account to patients, for markets area patients abide underserved by absolute therapies. The Aggregation anticipates that abounding of its accepted and approaching development programs may accredit the Aggregation to advance a authoritative alleyway that would accumulate analytic development and advance the aisle appear commercialization. Learn added at www.zosanopharma.com.
About Lincoln Park Basic Fund, LLC
["388"]LPC is an institutional broker headquartered in Chicago, Illinois which manages a portfolio of investments in accessible and clandestine entities. These investments are in a advanced ambit of companies and industries emphasizing action sciences, specialty financing, cleantech, energy, absolute acreage and technology. LPC’s investments ambit from multiyear banking commitments to armamentarium advance to appropriate bearings financings to abiding cardinal basic alms companies certainty, adaptability and consistency. For added information, appointment www.lpcfunds.com.
Forward-Looking Statements
This columnist absolution contains advanced statements apropos the timing and bulk of any gain that the Aggregation may accept beneath the accepted banal acquirement agreement, timing of accepted analytic development milestones, capability of our basic assets and charge for approaching allotment and added approaching contest and expectations. Readers are apprenticed to accede statements that accommodate the words "may," "will," "would," "could," "should," "might," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," "unaudited," "approximately" or the abrogating of those words or added commensurable words to be ambiguous and forward-looking. These statements are accountable to risks and uncertainties that are difficult to adumbrate and absolute outcomes may alter materially. These accommodate risks and uncertainties include, after limitation, the accident that we may not accept admission to the abounding $35 actor in gain beneath the acquirement acceding (due to the limitations independent therein) and accept no obligation to advertise any shares pursuant thereto, as able-bodied as risks associated with the action of discovering, developing and commercializing articles that are safe and able for use as animal therapeutics, risks inherent in the accomplishment to body a business about such articles and added risks and uncertainties declared beneath the branch "Risk Factors" in the Company's best contempo anniversary address on Form 10-K.. Although we accept that the expectations reflected in these advanced statements are reasonable, we cannot in any way agreement that the approaching results, akin of activity, achievement or contest and affairs reflected in advanced statements will be accomplished or occur. All advanced statements are based on advice currently accessible to Zosano and Zosano assumes no obligation to amend any such advanced statements.
["582"]
Piper Jaffray announced Zosano Pharma (NASDAQ:ZSAN), bumping up ... | zsan stock priceZosano Contact:Georgia ErbezChief Business Officer andChief Banking Officer510-745-1200
["291"]
Zosano Pharma Corp (ZSAN) Shares Fall on the Back of Equity ... | zsan stock price["291"]
Historic Stock Lookup - Zosano Pharma | zsan stock price["452.02"]
ZOSANO PHARMA CORP (NASDAQ:ZSAN) — Stock Chart and Quote | TradingView | zsan stock price["314.28"]
Varian Medical Systems, Inc. (VAR) registers a price change of ... | zsan stock price["679"]
Zosano Pharma Corporation (ZSAN) Stock Report – NASDAQ.com ... | zsan stock price["702.28"]
Can Zosano Pharma Corp (NASDAQ:ZSAN) Stock Turn Around? | zsan stock price["388"]
ZSAN : Summary for Zosano Pharma Corporation - Yahoo Finance | zsan stock price["452.02"]
ZOSANO PHARMA CORP (NASDAQ:ZSAN) — Stock Chart and Quote | TradingView | zsan stock price